A detailed history of Two Sigma Investments, LP transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 341,761 shares of AVIR stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
341,761
Previous 375,075 8.88%
Holding current value
$1.11 Million
Previous $1.24 Million 7.82%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.17 - $4.02 $105,605 - $133,922
-33,314 Reduced 8.88%
341,761 $1.14 Million
Q2 2024

Aug 14, 2024

BUY
$3.31 - $4.04 $9,350 - $11,413
2,825 Added 0.76%
375,075 $1.24 Million
Q1 2024

May 15, 2024

BUY
$3.09 - $4.56 $649,953 - $959,154
210,341 Added 129.91%
372,250 $1.5 Million
Q4 2023

Feb 14, 2024

BUY
$2.8 - $3.35 $301,876 - $361,173
107,813 Added 199.3%
161,909 $493,000
Q3 2023

Nov 14, 2023

SELL
$3.0 - $3.79 $363,252 - $458,908
-121,084 Reduced 69.12%
54,096 $162,000
Q2 2023

Aug 14, 2023

BUY
$3.21 - $5.06 $562,327 - $886,410
175,180 New
175,180 $655,000
Q3 2022

Nov 14, 2022

SELL
$5.49 - $8.79 $66,072 - $105,787
-12,035 Reduced 10.89%
98,482 $560,000
Q2 2022

Aug 15, 2022

SELL
$5.33 - $8.18 $2.62 Million - $4.02 Million
-491,485 Reduced 81.64%
110,517 $785,000
Q1 2022

May 16, 2022

SELL
$5.5 - $9.19 $1.03 Million - $1.72 Million
-187,663 Reduced 23.76%
602,002 $4.35 Million
Q4 2021

Feb 14, 2022

BUY
$7.67 - $44.59 $6.06 Million - $35.2 Million
789,665 New
789,665 $7.06 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $271M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.